153 related articles for article (PubMed ID: 21095548)
1. Nutrition and gastroenteropancreatic neuroendocrine tumors.
Go VL; Srihari P; Kamerman Burns LA
Endocrinol Metab Clin North Am; 2010 Dec; 39(4):827-37. PubMed ID: 21095548
[TBL] [Abstract][Full Text] [Related]
2. Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapy.
Oberg KE; Reubi JC; Kwekkeboom DJ; Krenning EP
Gastroenterology; 2010 Sep; 139(3):742-53, 753.e1. PubMed ID: 20637207
[TBL] [Abstract][Full Text] [Related]
3. The p53 network as therapeutic target in gastroenteropancreatic neuroendocrine neoplasms.
Briest F; Grabowski P
Cancer Treat Rev; 2015 May; 41(5):423-30. PubMed ID: 25837868
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers and molecular imaging in gastroenteropancreatic neuroendocrine tumors.
Lindholm DP; Oberg K
Horm Metab Res; 2011 Nov; 43(12):832-7. PubMed ID: 22009449
[TBL] [Abstract][Full Text] [Related]
5. Nutritional Complications and the Management of Patients with Gastroenteropancreatic Neuroendocrine Tumors.
Laing E; Kiss N; Michael M; Krishnasamy M
Neuroendocrinology; 2020; 110(5):430-442. PubMed ID: 31550712
[TBL] [Abstract][Full Text] [Related]
6. The clinical relevance of chromogranin A as a biomarker for gastroenteropancreatic neuroendocrine tumors.
Lawrence B; Gustafsson BI; Kidd M; Pavel M; Svejda B; Modlin IM
Endocrinol Metab Clin North Am; 2011 Mar; 40(1):111-34, viii. PubMed ID: 21349414
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of somatostatin receptor subtype expression in human neuroendocrine tumors using two sets of new monoclonal antibodies.
Lambertini C; Barzaghi-Rinaudo P; D'Amato L; Schulz S; Nuciforo P; Schmid HA
Regul Pept; 2013 Nov; 187():35-41. PubMed ID: 24188818
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and predictive biomarkers in gastroenteropancreatic neuroendocrine tumors.
Stevenson R; Libutti SK; Saif MW
JOP; 2013 Mar; 14(2):155-7. PubMed ID: 23474561
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetics of gastroenteropancreatic neuroendocrine tumors.
Starker LF; Carling T
Curr Opin Oncol; 2009 Jan; 21(1):29-33. PubMed ID: 19125015
[TBL] [Abstract][Full Text] [Related]
10. Gastroenteropancreatic endocrine tumors.
Meeker A; Heaphy C
Mol Cell Endocrinol; 2014 Apr; 386(1-2):101-20. PubMed ID: 23906538
[TBL] [Abstract][Full Text] [Related]
11. Hormone secreting gastro-entero-pancreatic neuroendocrine neoplasias (GEP-NEN): When to consider, how to diagnose?
Fottner C; Ferrata M; Weber MM
Rev Endocr Metab Disord; 2017 Dec; 18(4):393-410. PubMed ID: 29256148
[TBL] [Abstract][Full Text] [Related]
12. Gastroenteropancreatic neuroendocrine tumors: update on therapeutics.
Ganetsky A; Bhatt V
Ann Pharmacother; 2012 Jun; 46(6):851-62. PubMed ID: 22589450
[TBL] [Abstract][Full Text] [Related]
13. Gastroenteropancreatic neuroendocrine tumours.
Modlin IM; Oberg K; Chung DC; Jensen RT; de Herder WW; Thakker RV; Caplin M; Delle Fave G; Kaltsas GA; Krenning EP; Moss SF; Nilsson O; Rindi G; Salazar R; Ruszniewski P; Sundin A
Lancet Oncol; 2008 Jan; 9(1):61-72. PubMed ID: 18177818
[TBL] [Abstract][Full Text] [Related]
14. Gastroenteropancreatic neuroendocrine tumor cancer stem cells: do they exist?
Grande E; Capdevila J; Barriuso J; Antón-Aparicio L; Castellano D
Cancer Metastasis Rev; 2012 Jun; 31(1-2):47-53. PubMed ID: 22105614
[TBL] [Abstract][Full Text] [Related]
15. Site- and grade-specific diversity of LINE1 methylation pattern in gastroenteropancreatic neuroendocrine tumours.
Stricker I; Tzivras D; Nambiar S; Wulf J; Liffers ST; Vogt M; Verdoodt B; Tannapfel A; Mirmohammadsadegh A
Anticancer Res; 2012 Sep; 32(9):3699-706. PubMed ID: 22993308
[TBL] [Abstract][Full Text] [Related]
16. TNF-alpha promoter single nucleotide polymorphisms in gastroenteropancreatic neuroendocrine tumors.
Berković M; Cacev T; Zjacić-Rotkvić V; Kapitanović S
Neuroendocrinology; 2006; 84(5):346-52. PubMed ID: 17164537
[TBL] [Abstract][Full Text] [Related]
17. The management of neuroendocrine tumours: A nutritional viewpoint.
Gallo M; Muscogiuri G; Pizza G; Ruggeri RM; Barrea L; Faggiano A; Colao A;
Crit Rev Food Sci Nutr; 2019; 59(7):1046-1057. PubMed ID: 29020456
[TBL] [Abstract][Full Text] [Related]
18. Polypeptide growth factors in gastroenteropancreatic neuroendocrine tumours.
Blicharz-Dorniak J; Kos-Kudła B; Kudła M; Foltyn W; Marek B; Siemińska L; Nowak M
Endokrynol Pol; 2007; 58(1):42-9. PubMed ID: 17354204
[TBL] [Abstract][Full Text] [Related]
19. An update on gastroenteropancreatic neuroendocrine tumors.
Cives M; Strosberg J
Oncology (Williston Park); 2014 Sep; 28(9):749-56, 758. PubMed ID: 25224471
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic therapy of gastroenteropancreatic (GEP) tumors.
Syrigos KN; Sitara D; Georgiou E; Harrington KJ
Anticancer Res; 2002; 22(2B):1311-4. PubMed ID: 12168943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]